Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery
Bret L Fisher,1 Rick Potvin2 1Eye Center of North Florida, Panama City, FL, USA; 2Science in Vision, Akron, NY, USA Purpose: To compare the relative effectiveness of a Tri-Moxi-Vanc intraocular solution injected transzonularly into the vitreous with the topical formulation of Pred-Moxi-Ketor (give...
Enregistré dans:
Auteurs principaux: | Fisher BL, Potvin R |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fe857fcd96ad4e1bb6013f953635a39a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prophylactic intracameral levofloxacin in cataract surgery – an evaluation of safety
par: Espiritu CR, et autres
Publié: (2017) -
Antibiotic prophylaxis: different practice patterns within and outside the United States
par: Schwartz SG, et autres
Publié: (2016) -
Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy
par: Shah TJ, et autres
Publié: (2018) -
Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery
par: Guell J, et autres
Publié: (2019) -
Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes
par: Joshi RS
Publié: (2016)